GR
GRI Bio, Inc.
GRI · NASDAQ
$1.81 -0.55% (-$0.01)
1M +6.43%
Market Cap $162.6K
P/E Ratio -
Div. Yield -
ROE 134.03%
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.02x
P/E N/A
P/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 93.76%
Asset turnover 0.00x
ROE 134.03%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 10.30x
Int. coverage N/A
Stability
19 /100
Unstable Beta -0.66x
Profitable years 0
EPS volatility 169.48%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GRI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
W. Marc Hertz
Employees
4
Headquarters
La Jolla
Upcoming events
13 NOV
Earnings
Upcoming earnings report